Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Sales, net	$ 37,488	$ 33,683
Cost of sales	33,095	28,800
Gross profit	4,393	4,883
Selling and administrative expenses	3,460	3,531
Operating income	933	1,352
Other income (expense), net:
Interest expense	(979)	(964)
Change in fair value of derivative instruments	$ 705	(21)
Impairment charge on investment in iBio, Inc.		(152)
Other income, net	$ 210	5
Total other expense, net	(64)	(1,132)
Income before income taxes	869	220
Income tax expense, net	134	89
Net income	735	$ 131
Change in fair value of derivative instruments	(705)
Interest expense on Convertible debt - CD Financial, LLC	326
Accretion of Convertible debt - CD Financial, LLC	110
Diluted net income	$ 466	$ 131
Basic net income per common share (in dollars per share)	$ 0.03	$ 0.01
Diluted net income per common share (in dollars per share)	$ 0.02	$ 0.01
Weighted average common shares outstanding - basic (in shares)	21,105,174	21,081,955
Add: Equivalent shares outstanding (in shares)	49,944	111,863
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)	8,230,769
Weighted average common shares outstanding - diluted (in shares)	29,385,887	21,193,818